Tubulysin derivatives
US9427479B2 · kind B2 · utility
3Cited by
1References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2015 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | Apr 10, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel tubulysin derivatives which may be useful as cytotoxic agents to provide therapeutic benefits in the treatment of various types of cancers, alone, as drug conjugates or in combination with other chemotherapies are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.